Levy Adam D. 4
4 · Acrivon Therapeutics, Inc. · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Levy Adam D.
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-08-01$1.26/sh−1,164$1,467→ 12,151 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.